| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Seaport Therapeutics, Inc. Common Stock (SPTX) has 4 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. SPTX is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 49.0K | $764.9K | - | |
| Other | 20.1K | $313.7K | - | |
| Dir | 12.3K | $191.2K | - | |
| 10% | 0 | - | +1.10M |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Arch Venture Partners Xii, LLC63 | 10% Owner | Buy | 1,100,000 | $18.00 | $19,800,000.00 | +21.2% |